Ophrma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ophrma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ophrma Today - Breaking & Trending Today

Pharmaceutical group's lawsuit over Medicare drug price program dismissed

(Reuters) -A federal judge on Monday dismissed a lawsuit by a major pharmaceutical industry trade association challenging a new program that allows Medicare to negotiate prices with drug companies for selected costly drugs. U.S. District Judge David Ezra in Austin, Texas, sided with President Joe Biden's administration in dismissing a lawsuit by the Pharmaceutical Research and Manufacturers of America (PhRMA) and two other groups that argued the program was unconstitutional. "We are disappointed with the court's decision, which does not address the merits of our lawsuit, and we are weighing our next legal steps," Nicole Longo, a PhRMA spokesperson, said in a statement. ....

United States , America Ph , Nicole Longo , Nate Raymond , Joe Biden , Michael Perry , David Ezra , Merck Co , National Infusion Center Association , Global Colon Cancer Association , Us Supreme Court , Us Centers For Medicare , Medicaid Service , Us Chamber , Judge David Ezra , President Joe Biden , Pharmaceutical Research , Inflation Reduction Act , Eight Amendment , Medicare Act , President Joe Biden , David Ezra , Medicare Act , Pharmaceutical Research And Manufacturers Of America , Industry Trade Association , Awsuit Filed ,

Federal judge tosses PhRMA lawsuit challenging Medicare drug negotiations

A Texas federal judge on Monday dismissed a lawsuit challenging the Biden administration’s Medicare drug price negotiations filed by the pharmaceutical industry lobbying group PhRMA. The decision marks a small victory for the Biden administration, as it’s the first time a court has outright dismissed a challenge to Medicare’s new price negotiation powers. There are… ....

United States , David Alan Ezra , Nicole Longo , National Infusion Center Association , Global Colon Cancer Association , Western District , Drug Companies , David Alan Ezra , Price Negotiation , Biden Administration , Lobbying Group , National Infusion Center Association , Price Negotiations ,

How Big Pharma is Fueling a Radical MAGA Agenda

Republicans’ Project 2025 blueprint is an assault on women’s health care. It would also end Biden’s Medicare drug-pricing plan ....

United States , Donald Trump , Joe Biden , Alex Schriver , Liz Zelnick , Milton Friedman , Drug Administration , Competitive Enterprise Institute , Democratic Party , Heritage Foundation , Supreme Court , Pacific Research Institute , American Legislative Exchange Council , Associated Press , Tea Party , Big Pharma , Pharmaceutical Research , American Commitment , Inflation Reduction Act , Rolling Stonereported , Drug Prices , Price Negotiation , Big Pharma , Biden Administration , Trump Administration , Project 2025 ,

Bottom Line: PhRMA adds lobbying firepower for PBM reform fight

Prescription drugs YC Consulting registered to lobby on prescription drug pricing and pharmacy benefit manager (PBM) transparency and reform on behalf of the influential trade association Pharmaceutical Research and Manufacturers of America (PhRMA). PhRMA has lobbied for legislation intended to make PBMs more transparent and flooded TV, radio and other media with ads blaming PBMs… ....

Capitol Hill , District Of Columbia , United States , White House , Brownstein Hyatt Farber Schreck , America Ph , James Moran , Yong Choe , Neal Patel , Geoffrey Burr , National Association Of Federal Equity Receivers , Trump White House Office Of Management , Traffic Safety Administration , Care Management Association , Rite Aid , National Association Of Chain Drug Stores , Department Of Transportation , Republican Study Committee , Pharmaceutical Research , Speaker Mike Johnson , National Association , Chain Drug , Pharmaceutical Care Management Association , National Highway Traffic Safety Administration , Federal Equity Receivers , Moran Global Strategies ,

No injunction yet for state's epinephrine affordability program

One of the latest state laws impacting prescription drug prices is a per se unconstitutional taking, a U.S. district judge said last week, but he refused to grant a preliminary injunction to shield manufacturers from the effects of Colorado’s new law while Teva Pharmaceuticals USA Inc.’s constitutional challenge moves through the courts. ....

United States , Teva Pharmaceuticals United States Inc , Teva Pharmaceuticals United States , Teva Pharmaceuticals Usa Inc , State Law , Drug Pricing , Viatris Inc ,